Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia? [PDF]
Selimoglu-Buet D +27 more
europepmc +1 more source
Auer Rods in Chronic Myelomonocytic Leukemia Can Change the Diagnosis
Smeeta Gajendra, Ranjit Kumar Sahoo
doaj +1 more source
Case Report: Coexistence of advanced systemic mastocytosis, chronic myelomonocytic Leukemia, and t(11;14)-positive plasma-cell neoplasm: a rare triple-clonal hematologic case. [PDF]
Yin J +6 more
europepmc +1 more source
BLAST demonstrates higher prognostic accuracy for survival than CPSS in Chinese patients with chronic myelomonocytic leukemia. [PDF]
Yan X, Feng G, Cai Z, Ma J, Xu S, Ge Z.
europepmc +1 more source
Connective tissue diseases combined with chronic myelomonocytic leukemia and myelofibrosis: a case report and literature review. [PDF]
Yin HQ, Jin S, Fu Y, Zhu HL, Li XF.
europepmc +1 more source
Vulnerability of SRSF2-mutated chronic myelomonocytic leukemia to perturbation of the cGAS-STING pathway. [PDF]
Chen Y +14 more
europepmc +1 more source
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients. [PDF]
Alsugair A +30 more
europepmc +1 more source
Correction: Balaian et al. Systemic Metabolic Changes in Plasma of Patients with Myelodysplastic Neoplasms and Chronic Myelomonocytic Leukemia. <i>Metabolites</i> 2026, <i>16</i>, 648. [PDF]
Balaian E +14 more
europepmc +1 more source
Timdarpacept (IMM01) combined with azacitidine (AZA) as first-line therapy in adults with higher risk chronic myelomonocytic leukemia (CMML): results from a prospective, multicenter, phase II study. [PDF]
Ma L +18 more
europepmc +1 more source
CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia. [PDF]
Fathima S +19 more
europepmc +1 more source

